Search Results
Aug 27, 2026, 09:00 ET CVS Pharmacy® and MinuteClinic® now offering updated flu vaccines nationwide
season."CDC recommends annual flu vaccination for nearly everyoneThe CDC recommends that everyone ages six months and older, with rare exceptions, receive an annual flu vaccine, with September and October generally being ideal times for vaccination ahead of peak flu activity. The updated
More news about: CVS Health
Aug 27, 2026, 08:00 ET PTC Therapeutics to Participate in Upcoming Investor Conferences
biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class
More news about: PTC Therapeutics, Inc.
Aug 27, 2026, 08:00 ET Four Scientists Awarded $3 Million for High-Impact Research to Advance New Answers for Tau-Driven Diseases
(RCF) was created in the early 1990s by Richard E. Rainwater, the late private equity investor and philanthropist. When Richard was diagnosed with a rare neurodegenerative disease and primary tauopathy called Progressive Supranuclear Palsy (PSP), the RCF expanded its mission to accelerate the development
More news about: The Rainwater Charitable Foundation
Aug 27, 2026, 07:02 ET Fosun International Reports 1H2026 Results: Total Revenue RMB86.96 Billion, Net Profit RMB1.72 Billion
of paediatric and adolescent patients with relapsed or refractory Langerhans cell histiocytosis (LCH), continuing to fill the gap in the treatment of rare diseases. In terms of neurodegenerative diseases, Fosun Pharma continued to advance its innovation pipeline. Building upon the rights obtained to develop,
More news about: Fosun
Aug 27, 2026, 02:15 ET Gaotu Techedu Announces Second Quarter 2026 Unaudited Financial Results
and drive continuous growth. The Company provides AI-powered, product-led learning solutions for learners from pre-school to adulthood. By combining rare, high-caliber teaching resources with AI-enhanced tools and content, Gaotu creates engaging and effective learning experiences delivered through both
More news about: Gaotu Techedu Inc.
Aug 27, 2026, 02:00 ET TEZSPIRE® DEMONSTRATES POSITIVE PHASE 3 RESULTS IN EOSINOPHILIC ESOPHAGITIS ACROSS BOTH CO-PRIMARY AND ALL KEY SECONDARY ENDPOINTS
what is known today. Amgen is advancing a broad and deep pipeline and portfolio of medicines to treat cancer, heart disease, inflammatory conditions, rare diseases and obesity and obesity-related conditions.Amgen has been
More news about: Amgen
Aug 27, 2026, 00:30 ET Jazz Pharmaceuticals Announces Pricing of Upsized Private Offering of $1.1 Billion of 1.875% Exchangeable Senior Notes due 2032 and Concurrent Ordinary Share Repurchases
purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with rare diseases — often with limited or no therapeutic options. We have a diverse portfolio of medicines, including leading therapies addressing epilepsies,
More news about: Jazz Pharmaceuticals plc
Aug 26, 2026, 22:26 ET Biosidus erweitert seine Produktionskapazitäten für Biologika und stärkt seine weltweiten Lieferkapazitäten für Agalsidase beta
zu stellen, die einen nachhaltigen und zuverlässigen Zugang zu hochwertigen biologischen Arzneimitteln anstreben", erklärte Mario Koch, Director of Rare Diseases.Nach der Markteinführung von Agalsidase Beta in Argentinien im Jahr 2025 treibt Biosidus die internationale Expansion seines Programms
More news about: Biosidus
Aug 26, 2026, 17:00 ET Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta
living with rare and chronic diseases. Expanding our productive capacity reinforces our commitment to making Biosidus' biotechnology capabilities available to healthcare systems seeking sustainable and reliable access to high-quality biologic medicines," said Mario Koch, Director of Rare Diseases.After
More news about: Biosidus
Aug 26, 2026, 17:00 ET Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta
living with rare and chronic diseases. Expanding our productive capacity reinforces our commitment to making Biosidus' biotechnology capabilities available to healthcare systems seeking sustainable and reliable access to high-quality biologic medicines," said Mario Koch, Director of Rare Diseases.After
More news about: Biosidus
Aug 26, 2026, 16:02 ET Secure Tickets Now for the Only Scheduled Phil Weiser and Victor Marx Exclusive Gubernatorial Forum on October 8, 2026
Chamber encourages attendees to buy tickets now rather than wait. The event is open to both Colorado Chamber members and non-members, providing a rare opportunity to hear directly from both candidates about their priorities, policies, and vision for Colorado's future."This is a unique opportunity
More news about: Colorado Chamber of Commerce
Aug 26, 2026, 15:29 ET GothamChess Joins BASILISK, Science's Esports Team, as Head of Chess
"BASILISK is like a renaissance of nerds. We are making nerdy games and nerdy activities cool, and bringing them to the mainstream.""Levy has a rare ability to take something as complex and intimidating as chess and make it accessible and genuinely entertaining for hundreds of millions if not billions
More news about: BASILISK
Aug 26, 2026, 15:00 ET Capital Group Announces Appointment of New Chief Information Officer
investment excellence, serve clients globally and scale our business," said Rob Klausner, Chief Operating Officer, Capital Group. "Guillermo brings a rare combination of deep technology expertise, operational leadership and global transformation experience. His track record leading large, complex organizations
More news about: THE CAPITAL GROUP COMPANIES, INC.
Aug 26, 2026, 13:27 ET Patients Representing the Power of Advanced Therapies to Take Center Stage at Emily Whitehead Foundation's 2026 Believe Ball
advocacy that define the Emily Whitehead Foundation's mission to expand access to advanced therapies for patients around the world facing cancer and rare diseases.The 2026 Warrior emcees include:
More news about: Emily Whitehead Foundation
Aug 26, 2026, 11:39 ET GCU TAKING STEPS TO OPEN NEW COLLEGE OF LAW, COLLEGE OF CONSTRUCTION AND INDUSTRIAL TECHNOLOGIES
pathways that incorporate fundamental academic skills and hands-on technical training that lead to careers in skilled trades.Such a model is rare among four-year universities – particularly being housed under one college -- but Mueller said GCU is embracing the approach as a way to serve students,
More news about: Grand Canyon University
Aug 26, 2026, 11:00 ET AIA Contract Documents Launches AI Assistant and Names Arijit "AJ" Saha Chief Technology Officer
contract-related tasks more efficiently."ACD has earned the trust of the industry for nearly 140 years," said Saha. "That foundation creates a rare opportunity to build intelligent, AI-native products that help project teams work with greater speed and clarity. I'm excited to lead this next chapter
More news about: AIA Contract Documents
Aug 26, 2026, 10:49 ET Graviton BioScience Corporation Announces Publication of Positive Ph1b Trial Results for GV101 (TDI01) in Chronic Graft versus Host Disease in Signal Transduction and Targeted Therapy, by Beijing Tide Pharmaceutical
III RCT planning for GV101 in cGvHD and plans to carry the high dose forward.About Chronic Graft versus Host DiseasecGvHD is a rare, serious and potentially fatal complication of allogeneic stem cell transplantation that affects about 18,700 people in the US and has a global incidence
More news about: Graviton BioScience Corporation
Aug 26, 2026, 10:31 ET Congenital Hyperinsulinism Market to Expand at a CAGR of 12% During the Forecast Period (2026-2036) as Rising Disease Recognition and Novel Therapies Fuel Market Growth | DelveInsight
insulin secretion may also support more personalized approaches to treatment.Increasing Detection of Rare Genetic Disorders: Although congenital hyperinsulinism is a rare disorder, advancements in diagnostic techniques, patient registries, and disease reporting mechanisms are improving
More news about: DelveInsight Business Research, LLP
Aug 26, 2026, 10:30 ET Interlune Implants Helium into Simulated Moon Dirt, Advancing the Ability to Test Moon-Bound Hardware on Earth
in-space economy. Central to the mission is harvesting natural resources in space, starting with helium-3 and also including hydrogen, oxygen, metals, rare earth elements, and water. Interlune has secured nearly $500 million in binding helium-3 purchase agreements from government and commercial customers.
More news about: Interlune
Aug 26, 2026, 10:07 ET BE DEADLINE: Levi & Korsinsky Reminds Bloom Energy Corporation Investors of Upcoming Securities Class Action Deadline
its business, operations, and prospects therefore lacked a reasonable basis.The Rare Earth Export Control FactorAccording to the lawsuit, Beijing's tightened export controls on rare earths and escalating U.S. tariff policy made the geographic origin of scandium a material fact
More news about: Levi & Korsinsky, LLP
Aug 26, 2026, 10:00 ET ALTO ADIGE WINES TO HOST WALKAROUND TASTING IN NEW YORK CITY ON OCTOBER 6
Time: The 'Dolomite Preservation' Effect" will examine the remarkable aging potential of Alto Adige whites through a tasting of current releases and rare library wines, with a focus on the influence of Dolomitic limestone, volcanic porphyry, and the region's alpine climate."New York is an essential
More news about: Consorzio Alto Adige Wines
Aug 26, 2026, 10:00 ET VASA Fitness Names Liz Crisafi Chief Marketing Officer
commercially minded leader we need as VASA enters its next stage of growth," said Michael Osanloo, Chief Executive Officer of VASA Fitness. "She has a rare ability to build brands that resonate deeply with consumers while bringing the performance discipline, customer insight and operational mindset needed
More news about: VASA Fitness
Aug 26, 2026, 10:00 ET Opioid Prescribing for Children's Coughs Falls to Just 4 in 10,000 Visits, New Analysis Finds
Aug. 26, 2026 /PRNewswire/ -- The once-common practice of prescribing opioid cough syrup for children has become exceedingly rare in the U.S., according to a new analysis of more than 100 million insurance claims conducted by Motive Medical Intelligence (Motive) using its Practicing
More news about: Motive Medical Intelligence
Aug 26, 2026, 09:00 ET ReviR Therapeutics Receives FDA Rare Pediatric Disease Designation for RTX-117 in Charcot-Marie-Tooth Disease
development of therapies for serious or life-threatening rare diseases that predominantly affect children. If RTX-117 is ultimately approved and meets applicable statutory requirements and program criteria, ReviR may be eligible to receive a Rare Pediatric Disease Priority Review Voucher (PRV). The voucher
More news about: ReviR Therapeutics
Aug 26, 2026, 08:48 ET Lingokids Hires Former Tilting Point Studio Head Mathias Royer to Lead Lingokids Studios
Lingokids at the forefront of the space as the ultimate fun, safe, and beneficial destination for kids around the world."Lingokids is one of the rare companies combining true entertainment craft with genuine purpose," said Royer. "With an ambitious platform strategy and exciting partnerships
More news about: Lingokids